Cargando…
Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
AIMS/INTRODUCTION: The purpose of the present study was to investigate the possible effect of oral magnesium sulfate (MgSO (4)) in the reduction of atherosclerosis plaques through inhibition of lectin‐like low‐density lipoprotein receptor‐1 (LOX‐1) gene expression in diabetic vessels. MATERIALS AND...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497581/ https://www.ncbi.nlm.nih.gov/pubmed/30328289 http://dx.doi.org/10.1111/jdi.12961 |
_version_ | 1783415485808771072 |
---|---|
author | Fazlali, Mina Kharazmi, Fatemeh Kamran, Mitra Malekzadeh, Kianoosh Talebi, Ardeshir Khosravi, Fatemeh Soltani, Nepton |
author_facet | Fazlali, Mina Kharazmi, Fatemeh Kamran, Mitra Malekzadeh, Kianoosh Talebi, Ardeshir Khosravi, Fatemeh Soltani, Nepton |
author_sort | Fazlali, Mina |
collection | PubMed |
description | AIMS/INTRODUCTION: The purpose of the present study was to investigate the possible effect of oral magnesium sulfate (MgSO (4)) in the reduction of atherosclerosis plaques through inhibition of lectin‐like low‐density lipoprotein receptor‐1 (LOX‐1) gene expression in diabetic vessels. MATERIALS AND METHODS: A total of 50 rats were divided into five groups, including non‐diabetic control, Mg‐treated non‐diabetic control, chronic diabetic, Mg‐treated chronic diabetic and insulin‐treated chronic diabetic. The induction of diabetes was carried out by streptozotocin. The Mg‐treated chronic diabetic and Mg‐treated non‐diabetic control groups were treated with 10 g/L of MgSO (4) added to their drinking water. The insulin‐treated chronic diabetic group received 2.5 U/kg of insulin twice per day. The fasting blood glucose level and bodyweight were determined weekly. Blood pressure measurement and the intraperitoneal glucose tolerance test were carried out after 16 weeks, and the plasma levels of Mg, lipid profile and oxidized low‐density lipoprotein cholesterol (oxLDL) were determined. The mesenteric bed was isolated and perfused according to the McGregor method. The aorta was isolated for LOX‐1 genes and proteins expression, and pathological investigation. RESULTS: MgSO (4) administration improved blood pressure, sensitivity to phenylephrine, intraperitoneal glucose tolerance test, lipid profile and plasma ox‐LDL level, and also lowered the blood glucose level to the normal range, and decreased LOX‐1 gene and protein expressions. Insulin decreased blood pressure, sensitivity to phenylephrine, blood glucose, lipid profiles and plasma oxLDL level, but it did not decrease LOX‐1 gene and protein expressions. CONCLUSIONS: The present findings suggested that MgSO (4) improves blood pressure and vessel structure through decreasing oxLDL, and LOX‐1 gene and protein expressions; however, insulin did not repair vessel structure, and LOX‐1 gene and protein expressions. |
format | Online Article Text |
id | pubmed-6497581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64975812019-05-07 Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels Fazlali, Mina Kharazmi, Fatemeh Kamran, Mitra Malekzadeh, Kianoosh Talebi, Ardeshir Khosravi, Fatemeh Soltani, Nepton J Diabetes Investig Articles AIMS/INTRODUCTION: The purpose of the present study was to investigate the possible effect of oral magnesium sulfate (MgSO (4)) in the reduction of atherosclerosis plaques through inhibition of lectin‐like low‐density lipoprotein receptor‐1 (LOX‐1) gene expression in diabetic vessels. MATERIALS AND METHODS: A total of 50 rats were divided into five groups, including non‐diabetic control, Mg‐treated non‐diabetic control, chronic diabetic, Mg‐treated chronic diabetic and insulin‐treated chronic diabetic. The induction of diabetes was carried out by streptozotocin. The Mg‐treated chronic diabetic and Mg‐treated non‐diabetic control groups were treated with 10 g/L of MgSO (4) added to their drinking water. The insulin‐treated chronic diabetic group received 2.5 U/kg of insulin twice per day. The fasting blood glucose level and bodyweight were determined weekly. Blood pressure measurement and the intraperitoneal glucose tolerance test were carried out after 16 weeks, and the plasma levels of Mg, lipid profile and oxidized low‐density lipoprotein cholesterol (oxLDL) were determined. The mesenteric bed was isolated and perfused according to the McGregor method. The aorta was isolated for LOX‐1 genes and proteins expression, and pathological investigation. RESULTS: MgSO (4) administration improved blood pressure, sensitivity to phenylephrine, intraperitoneal glucose tolerance test, lipid profile and plasma ox‐LDL level, and also lowered the blood glucose level to the normal range, and decreased LOX‐1 gene and protein expressions. Insulin decreased blood pressure, sensitivity to phenylephrine, blood glucose, lipid profiles and plasma oxLDL level, but it did not decrease LOX‐1 gene and protein expressions. CONCLUSIONS: The present findings suggested that MgSO (4) improves blood pressure and vessel structure through decreasing oxLDL, and LOX‐1 gene and protein expressions; however, insulin did not repair vessel structure, and LOX‐1 gene and protein expressions. John Wiley and Sons Inc. 2018-12-04 2019-05 /pmc/articles/PMC6497581/ /pubmed/30328289 http://dx.doi.org/10.1111/jdi.12961 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Fazlali, Mina Kharazmi, Fatemeh Kamran, Mitra Malekzadeh, Kianoosh Talebi, Ardeshir Khosravi, Fatemeh Soltani, Nepton Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
title | Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
title_full | Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
title_fullStr | Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
title_full_unstemmed | Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
title_short | Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
title_sort | effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497581/ https://www.ncbi.nlm.nih.gov/pubmed/30328289 http://dx.doi.org/10.1111/jdi.12961 |
work_keys_str_mv | AT fazlalimina effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels AT kharazmifatemeh effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels AT kamranmitra effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels AT malekzadehkianoosh effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels AT talebiardeshir effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels AT khosravifatemeh effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels AT soltaninepton effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels |